Shree Ganesh Bio

{
  "main_header": {
    "sid": 999946,
    "name": "Shree Ganesh Bio",
    "stock_name": "Shree Ganesh Bio",
    "full_name": "Shree Ganesh Biotech India Ltd",
    "name_url": "stocks-analysis/shree-ganesh-bio",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "0.53",
    "chg": -0.01,
    "chgp": "-1.85%",
    "dir": -1,
    "prev_price": "0.54",
    "mcapval": "21.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 539470,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 61,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE051N01026",
    "curr_date": "Aug 10, 03:30 PM",
    "curr_time": "07:34 AM",
    "last_traded_at": "Aug 10, 03:30 PM IST",
    "bse_nse_vol": "5.91 lacs",
    "exc_status": "Active",
    "traded_date": "Aug 10, 2026",
    "traded_date_str": "2026 08 10",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/shree-ganesh-bio-999946-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Are Shree Ganesh Biotech India Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-shree-ganesh-biotech-india-ltd-latest-results-good-or-bad-4138475",
        "imagepath": "",
        "date": "2026-08-05 19:25:09",
        "description": "Shree Ganesh Biotech India Ltd's latest financial results reflect a challenging operational landscape. In the fiscal year 2025, the company reported net sales of ₹22.00 crores, which represents a modest year-on-year growth of 10.0% from ₹20.00 crores in FY24. However, this growth is overshadowed by significant operational difficulties, as the company incurred an operating loss of ₹1.00 crore, leading to a negative operating margin of 4.5%. This marks a troubling trend, as the company has transitioned from generating operating profits in previous years to facing losses.\n\nThe financial trajectory over the past few years reveals extreme volatility in revenues, with a dramatic decline from ₹72.00 crores in FY22 to ₹20.00 crores in FY24, before a slight recovery in FY25. This pattern suggests underlying instability rather than cyclical fluctuations. Additionally, the company's return on equity has fallen to 0.80..."
      },
      {
        "title": "Shree Ganesh Biotech India Q1 FY27: Mounting Losses Deepen Financial Crisis",
        "link": "https://www.marketsmojo.com/news/result-analysis/shree-ganesh-biotech-india-q1-fy27-mounting-losses-deepen-financial-crisis-4136546",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/ShreeGaneshBiot_quaterlyResult_4136546.png",
        "date": "2026-08-04 22:31:47",
        "description": "Shree Ganesh Biotech India Ltd., a micro-cap pharmaceutical company with a market capitalisation of ₹22.00 crores, continues to struggle with operational profitability as the company posted operating losses in Q1 FY27. Trading at ₹0.55 per share as of August 4, 2026, the stock has witnessed a precipitous decline of 30.38% over the past year, substantially underperforming the Sensex which declined 3.20% during the same period. With zero promoter holding, minimal institutional interest at 1.42%, and a concerning \"Strong Sell\" rating with a score of just 12 out of 100, the company faces mounting challenges in an already competitive pharmaceutical sector."
      },
      {
        "title": "Shree Ganesh Biotech India Ltd Slides to All-Time Low Amid Prolonged Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shree-ganesh-biotech-india-ltd-hits-all-time-low-at-rs052-amid-bearish-market-trends-4128180",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/ShreeGaneshBiot_priceRelatedfactors_4128180.png",
        "date": "2026-07-30 09:35:07",
        "description": "The stock of Shree Ganesh Biotech India Ltd has reached a fresh all-time low of Rs.0.52 on 30 Jul 2026, extending a multi-year decline that has seen the share price lose over 90% of its value in the past five years. Despite some recent upticks in profitability, the share price continues to reflect significant investor caution."
      },
      {
        "title": "When is the next results date for Shree Ganesh Biotech India Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-shree-ganesh-biotech-india-ltd-4116740",
        "imagepath": "",
        "date": "2026-07-22 23:17:34",
        "description": "The next results date for Shree Ganesh Biotech India Ltd is scheduled for August 4, 2026...."
      },
      {
        "title": "Markets Rise, But Shree Ganesh Biotech India Ltd Slides to All-Time Low Amid Stock-Specific Sell-Off",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shree-ganesh-biotech-india-ltd-hits-all-time-low-amidst-prolonged-downtrend-4108707",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/ShreeGaneshBiot_priceRelatedfactors_4108707.png",
        "date": "2026-07-20 09:34:06",
        "description": "Despite a broadly positive market environment, Shree Ganesh Biotech India Ltd has continued its downward trajectory, hitting a fresh all-time low of ₹0.55 on 20 Jul 2026. This marks a significant milestone in the stock’s prolonged decline, underscoring persistent challenges that have yet to be fully addressed."
      },
      {
        "title": "Markets Rise, But Shree Ganesh Biotech India Ltd Slides to All-Time Low Amid Stock-Specific Sell-Off",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shree-ganesh-biotech-india-ltd-hits-all-time-low-amidst-prolonged-downtrend-4079033",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/ShreeGaneshBiot_priceRelatedfactors_4079033.png",
        "date": "2026-06-30 13:42:54",
        "description": "Despite a broadly positive market environment, Shree Ganesh Biotech India Ltd has continued its downward trajectory, hitting a fresh all-time low of ₹0.56 on 30 Jun 2026. The stock’s persistent underperformance contrasts sharply with sector gains and broader indices, underscoring a complex interplay of valuation pressures and financial challenges."
      },
      {
        "title": "Shree Ganesh Biotech India Ltd Falls 4.92% Amid All-Time Low and Bearish Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shree-ganesh-biotech-india-ltd-falls-492-amid-all-time-low-and-bearish-momentum-4051151",
        "imagepath": "",
        "date": "2026-06-13 11:03:08",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>8 Jun:</strong> Stock opens at Rs.0.60, down 1.64% as Sensex falls 1.33%</p>\n                    <p><strong>9 Jun:</strong> Stock unchanged at Rs.0.60, Sensex rebounds +0.88%</p>\n                    <p><strong>10 Jun:</strong> Stock dips to Rs.0.59 (-1.67%), Sensex slips -0.61%</p>\n                    <p><strong>11 Jun:</strong> Stock hits 52-week low Rs.0.52 and all-time low Rs.0.58, down 3.39%, Sensex down 0.53%</p>\n                    <p><strong>12 Jun:</strong> Stock recovers slightly to Rs.0.58 (+1.75%), Sensex surges +2.20%</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><di..."
      },
      {
        "title": "Shree Ganesh Biotech India Ltd Falls to 52-Week Low of Rs 0.52 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shree-ganesh-biotech-india-ltd-falls-to-52-week-low-of-rs052-4046747",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/ShreeGaneshBiot_priceRelatedfactors_4046747.png",
        "date": "2026-06-11 13:41:16",
        "description": "A sharp decline in the share price has dragged Shree Ganesh Biotech India Ltd to a fresh 52-week low of Rs 0.52 on 11 Jun 2026, marking a 34.83% drop over the past year and signalling sustained pressure on this micro-cap pharmaceutical stock."
      },
      {
        "title": "Shree Ganesh Biotech India Ltd Extends Losing Streak, Hits All-Time Low Amid Financial Struggles",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shree-ganesh-biotech-india-ltd-hits-all-time-low-amidst-prolonged-downtrend-4046738",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/ShreeGaneshBiot_priceRelatedfactors_4046738.png",
        "date": "2026-06-11 13:12:48",
        "description": ""
      }
    ],
    "total": 171,
    "sid": "999946",
    "stock_news_url": "https://www.marketsmojo.com/news/shree-ganesh-biotech-india-999946"
  },
  "announcements": [
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On 4Th August 2026.",
      "datetime": "04-Aug-2026",
      "details": "Pursuant to Second proviso to Regulation 30(6) and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that the Board of Directors of the Company in their meeting held on today i.e. Tuesday 4th August2026. at the Registered Office of the Company and transacted the following major businesses: 1.) Considered and approved Un-audited financial results for the quarter ended as on 30th June 2026. The board meeting commented at 03:50 PM and concluded at 04:10 PM Please take the above intimation in your records. Thanking You.",
      "source": "BSE"
    },
    {
      "caption": "Disclosure Under Regulation 32(1) Of SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015",
      "datetime": "04-Aug-2026",
      "details": "PFA",
      "source": "BSE"
    },
    {
      "caption": "Regulation 33 Read With Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations)",
      "datetime": "04-Aug-2026",
      "details": "PFA",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Shree Ganesh Biotech India Ltd has announced <strong>1:10</strong> stock split, ex-date: 10 Feb 22",
          "dt": "2022-02-10",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Shree Ganesh Biotech India Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 27 Apr 22",
          "dt": "2022-04-27",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Are Shree Ganesh Biotech India Ltd latest results good or bad?

2026-08-05 19:25:09

Shree Ganesh Biotech India Ltd's latest financial results reflect a challenging operational landscape. In the fiscal year 2025, the company reported net sales of ₹22.00 crores, which represents a modest year-on-year growth of 10.0% from ₹20.00 crores in FY24. However, this growth is overshadowed by significant operational difficulties, as the company incurred an operating loss of ₹1.00 crore, leading to a negative operating margin of 4.5%. This marks a troubling trend, as the company has transitioned from generating operating profits in previous years to facing losses. The financial trajectory over the past few years reveals extreme volatility in revenues, with a dramatic decline from ₹72.00 crores in FY22 to ₹20.00 crores in FY24, before a slight recovery in FY25. This pattern suggests underlying instability rather than cyclical fluctuations. Additionally, the company's return on equity has fallen to 0.80...

Read full news article

Shree Ganesh Biotech India Q1 FY27: Mounting Losses Deepen Financial Crisis

2026-08-04 22:31:47

Shree Ganesh Biotech India Ltd., a micro-cap pharmaceutical company with a market capitalisation of ₹22.00 crores, continues to struggle with operational profitability as the company posted operating losses in Q1 FY27. Trading at ₹0.55 per share as of August 4, 2026, the stock has witnessed a precipitous decline of 30.38% over the past year, substantially underperforming the Sensex which declined 3.20% during the same period. With zero promoter holding, minimal institutional interest at 1.42%, and a concerning "Strong Sell" rating with a score of just 12 out of 100, the company faces mounting challenges in an already competitive pharmaceutical sector.

Read full news article

Shree Ganesh Biotech India Ltd Slides to All-Time Low Amid Prolonged Downtrend

2026-07-30 09:35:07

The stock of Shree Ganesh Biotech India Ltd has reached a fresh all-time low of Rs.0.52 on 30 Jul 2026, extending a multi-year decline that has seen the share price lose over 90% of its value in the past five years. Despite some recent upticks in profitability, the share price continues to reflect significant investor caution.

Read full news article

When is the next results date for Shree Ganesh Biotech India Ltd?

2026-07-22 23:17:34

The next results date for Shree Ganesh Biotech India Ltd is scheduled for August 4, 2026....

Read full news article

Markets Rise, But Shree Ganesh Biotech India Ltd Slides to All-Time Low Amid Stock-Specific Sell-Off

2026-07-20 09:34:06

Despite a broadly positive market environment, Shree Ganesh Biotech India Ltd has continued its downward trajectory, hitting a fresh all-time low of ₹0.55 on 20 Jul 2026. This marks a significant milestone in the stock’s prolonged decline, underscoring persistent challenges that have yet to be fully addressed.

Read full news article

Markets Rise, But Shree Ganesh Biotech India Ltd Slides to All-Time Low Amid Stock-Specific Sell-Off

2026-06-30 13:42:54

Despite a broadly positive market environment, Shree Ganesh Biotech India Ltd has continued its downward trajectory, hitting a fresh all-time low of ₹0.56 on 30 Jun 2026. The stock’s persistent underperformance contrasts sharply with sector gains and broader indices, underscoring a complex interplay of valuation pressures and financial challenges.

Read full news article

Shree Ganesh Biotech India Ltd Falls 4.92% Amid All-Time Low and Bearish Momentum

2026-06-13 11:03:08

Key Events This Week

8 Jun: Stock opens at Rs.0.60, down 1.64% as Sensex falls 1.33%

9 Jun: Stock unchanged at Rs.0.60, Sensex rebounds +0.88%

10 Jun: Stock dips to Rs.0.59 (-1.67%), Sensex slips -0.61%

11 Jun: Stock hits 52-week low Rs.0.52 and all-time low Rs.0.58, down 3.39%, Sensex down 0.53%

12 Jun: Stock recovers slightly to Rs.0.58 (+1.75%), Sensex surges +2.20%

Week Open

Read full news article

Shree Ganesh Biotech India Ltd Falls to 52-Week Low of Rs 0.52 as Sell-Off Deepens

2026-06-11 13:41:16

A sharp decline in the share price has dragged Shree Ganesh Biotech India Ltd to a fresh 52-week low of Rs 0.52 on 11 Jun 2026, marking a 34.83% drop over the past year and signalling sustained pressure on this micro-cap pharmaceutical stock.

Read full news article

Shree Ganesh Biotech India Ltd Extends Losing Streak, Hits All-Time Low Amid Financial Struggles

2026-06-11 13:12:48

Read full news article

View All News